HUTCHMED (China) (HCM) EBITDA Margin: 2014-2025

Historic EBITDA Margin for HUTCHMED (China) (HCM) over the last 4 years, with Jun 2025 value amounting to -0.31%.

  • HUTCHMED (China)'s EBITDA Margin rose 45.00% to -0.31% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.84%, marking a year-over-year increase of 674.00%. This contributed to the annual value of -0.41% for FY2024, which is 514.00% down from last year.
  • According to the latest figures from Q2 2025, HUTCHMED (China)'s EBITDA Margin is -0.31%, which was down 100.00% from 10,292.00% recorded in Q4 2024.
  • In the past 5 years, HUTCHMED (China)'s EBITDA Margin registered a high of 10,292.00% during Q4 2024, and its lowest value of -172.21% during Q4 2021.
  • Moreover, its 3-year median value for EBITDA Margin was -0.46% (2023), whereas its average is 2,572.58%.
  • Within the past 5 years, the most significant YoY rise in HUTCHMED (China)'s EBITDA Margin was 29,276bps (2021), while the steepest drop was 17,283bps (2021).
  • HUTCHMED (China)'s EBITDA Margin (Quarterly) stood at -172.21% in 2021, then spiked by 17,202bps to -0.18% in 2022, then reached -0.60% in 2023, then dropped by 15bps to 10,292.00% in 2024, then surged by 45bps to -0.31% in 2025.
  • Its last three reported values are -0.31% in Q2 2025, 10,292.00% for Q4 2024, and -0.76% during Q2 2024.